Novartis presents data on long-term treatment with Zolgensma InformationNewsTreatments & Research Monday, 22 May 2023
Taldefgrobep Alfa Receives FDA Fast Track Designation for SMA InformationTreatments & Research Sunday, 14 May 2023
NHS England Provides Further Guidance around Definition of Non-Success of Zolgensma InformationNewsTreatments & Research Monday, 24 April 2023
Results Published from STRONG Trial of Zolgensma InformationNewsTreatments & Research Wednesday, 12 April 2023
Conversations with health professionals – new webinar! InformationTreatments & Research Thursday, 9 March 2023